BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 22725609)

  • 1. The role of bicarbonate in platelet additive solution for apheresis platelet concentrates stored with low residual plasma.
    Radwanski K; Min K
    Transfusion; 2013 Mar; 53(3):591-9. PubMed ID: 22725609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the automated collection and extended storage of apheresis platelets in additive solution.
    Johnson L; Winter KM; Hartkopf-Theis T; Reid S; Kwok M; Marks DC
    Transfusion; 2012 Mar; 52(3):503-9. PubMed ID: 21880041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro variables of apheresis platelets are stably maintained for 7 days with 5% residual plasma in a glucose and bicarbonate salt solution, PAS-5.
    Radwanski K; Wagner SJ; Skripchenko A; Min K
    Transfusion; 2012 Jan; 52(1):188-94. PubMed ID: 21790624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets.
    Ringwald J; Haager B; Krex D; Zimmermann R; Strasser E; Antoon M; De Schrijver E; Eckstein R
    Transfusion; 2006 Jun; 46(6):942-8. PubMed ID: 16734810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro evaluation of apheresis platelets stored with 100% plasma versus bicarbonated Ringer's solution with less than 5% plasma.
    Oikawa S; Sasaki D; Kikuchi M; Sawamura Y; Itoh T
    Transfusion; 2013 Mar; 53(3):655-60. PubMed ID: 22804481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro quality.
    Ringwald J; Walz S; Zimmermann R; Zingsem J; Strasser E; Weisbach V; Eckstein R
    Vox Sang; 2005 Jul; 89(1):11-8. PubMed ID: 15938735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of in vitro storage properties of apheresis platelets suspended in a bicarbonate-containing additive solution with low levels of plasma and stored with a 24-hour interruption of agitation.
    Skripchenko A; Turgeon A; Thompson-Montgomery D; Awatefe H; Wagner SJ
    Vox Sang; 2014 May; 106(4):337-43. PubMed ID: 24330192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of immediate or delayed addition of platelet additive solution on the in vitro quality of apheresis platelets.
    Ringwald J; Tully S; Geier C; Hauck B; Weiss D; Callaert M; Eckstein R
    Transfusion; 2012 Jun; 52(6):1237-44. PubMed ID: 22070790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over.
    Sandgren P; Mayaudon V; Payrat JM; Sjödin A; Gulliksson H
    Vox Sang; 2010 Apr; 98(3 Pt 2):415-22. PubMed ID: 19788514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
    Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
    Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo quality of leukoreduced apheresis platelets stored in a new platelet additive solution.
    Dumont LJ; Cancelas JA; Graminske S; Friedman KD; Vassallo RR; Whitley PH; Rugg N; Dumont DF; Herschel L; Siegal AH; Szczepiorkowski ZM; Fender L; Razatos A
    Transfusion; 2013 May; 53(5):972-80. PubMed ID: 22882530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of calcium and phosphate in a bicarbonate-containing platelet additive solution with low plasma levels in maintaining key in vitro platelet storage parameters.
    Skripchenko A; Turgeon A; Thompson-Montgomery D; Awatefe H; Wagner SJ
    Transfusion; 2017 Feb; 57(2):349-356. PubMed ID: 27859382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro evaluation of apheresis platelets stored with 100% plasma or 65% platelet additive solution III/35% plasma and including periods without agitation under simulated shipping conditions.
    Moroff G; Kurtz J; Seetharaman S; Skripchenko A; Awatefe H; Thompson-Montgomery D; Myrup A; Wagner SJ
    Transfusion; 2012 Apr; 52(4):834-43. PubMed ID: 22014086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium is a key constituent for maintaining the in vitro properties of platelets suspended in the bicarbonate-containing additive solution M-sol with low plasma levels.
    Wagner SJ; Skripchenko A; Myrup A; Thompson-Montgomery D; Awatefe H; Moroff G
    Transfusion; 2010 May; 50(5):1028-35. PubMed ID: 20030790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of pH on stored human platelets.
    Dekkers DW; De Cuyper IM; van der Meer PF; Verhoeven AJ; de Korte D
    Transfusion; 2007 Oct; 47(10):1889-95. PubMed ID: 17880616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light.
    Wagner SJ; Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Moroff G; Carmichael P; Lin L
    Transfusion; 2009 Apr; 49(4):704-10. PubMed ID: 19171001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of platelet in vitro properties during 7-day storage in M-sol with a 30-hour interruption of agitation.
    Wagner SJ; Myrup A; Awatefe H; Thompson-Montgomery D; Hirayama J; Skripchenko A
    Transfusion; 2008 Dec; 48(12):2501-607. PubMed ID: 18764828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Washing platelets with new additive solutions: aspects on the in vitro quality after 48 hours of storage.
    Ringwald J; Althoff F; Zimmermann R; Strasser E; Weisbach V; Zingsem J; Eckstein R
    Transfusion; 2006 Feb; 46(2):236-43. PubMed ID: 16441601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activation and residual activation potential during storage of hyperconcentrated platelet products in two different platelet additive solutions.
    Vetlesen A; Mirlashari MR; Torsheim IA; Kjeldsen-Kragh J
    Transfusion; 2005 Aug; 45(8):1349-55. PubMed ID: 16078925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assessment of platelets stored in a modified platelet additive solution with trehalose at low temperature (10 °C) and in vivo effects on rabbit model of thrombocytopenia.
    Wang X; Fan Y; Shi R; Li J; Zhao S
    Platelets; 2015; 26(1):72-9. PubMed ID: 24499059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.